Development of a Behavioral Team Intervention for Obsessive Compulsive Disorder
NCT ID: NCT02616341
Last Updated: 2017-08-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
51 participants
INTERVENTIONAL
2012-11-30
2016-02-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
ERP to Improve Functioning in Veterans With OCD
NCT05240924
Exposure and Response Prevention With Behavioral- Versus Cognitive Therapy Rationale in Obsessive Compulsive Disorder
NCT00184262
Cognitive Behavioral Therapy Plus Motivational Interviewing for Treatment of Obsessive-Compulsive Disorder
NCT00316316
Assessing Models of Exposure Therapy
NCT01679457
Inference-Based Cognitive Therapy Versus Exposure and Response Prevention for Obsessive-Compulsive Disorder
NCT03677947
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Team ERP (T-ERP) Intervention
The ERP team intervention (T-ERP) consists of 25 sessions over 20 weeks with four components: (a) 3-4 pretherapy individual session with therapist, (b) 12 weekly group sessions (90-mins) led by a therapist and, (c) 10 individual coaching sessions with a case manager during weeks 2-11 of the group, and (d) 2 booster group sessions to reinforce relapse prevention
Team ERP (T-ERP) Intervention
Treatment as Usual (TAU)
Treatment as Usual (TAU) includes standard community treatment consisting of a personalized treatment plan and assistance with treatment referrals to available community resources
Treatment as Usual (TAU)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Team ERP (T-ERP) Intervention
Treatment as Usual (TAU)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. English speaking
3. Primary DSM-IV OCD (identified by the patient and therapist as the most problematic disorder over the past year)
4. At least moderate severity OCD (YBOCS \> 16)
5. Not currently on psychotropic medications or on the same psychotropic medications for at least 4 weeks prior to screening
6. Have never received 10 or more sessions of ERP
7. Not currently attending psychotherapy for OCD
8. Low-income based on the U.S. Housing and Urban Development (HUDs) threshold for RI (less than $41,000 per year for individuals).
Exclusion Criteria
2. Prominent suicidal ideation
3. Current psychosis, mania, alcohol or drug dependence as assessed by the SCID-P.
4. Prominent Hoarding
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Mental Health (NIMH)
NIH
Butler Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Maria Mancebo, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Butler Hospital, Providence RI 02906
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1005-008
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.